EXEL EXELIXIS, INC.
Nasdaq · SEC CIK 939767 · EDGAR
- Bought, last 12 months
- $1.19M 1 purchases by 1 insiders
- Sold, last 12 months
- $42.24M 24 sales by 12 insiders
- Filings on record
- 313 since 2021-07-08, latest 2026-08-12 19:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Aftab Dana | EVP, Research, Development | — | $7.70M |
| Haley Patrick J. | EVP, Commercial | — | $7.60M |
| Smith Julie | Dir | — | $4.69M |
| WYSZOMIERSKI JACK L | Dir | — | $4.58M |
| Senner Christopher J. | EVP, CFO | — | $4.56M |
| PAPADOPOULOS STELIOS | Dir | — | $4.36M |
| POSTE GEORGE | Dir | — | $2.74M |
| Beckerle Mary C | Dir | — | $1.93M |
| Oliver Bob | Dir | — | $1.33M |
| Caligan Partners LP | Dir, See Remarks | $1.19M | — |
Transactions 443
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-12 19:34 | 2026-08-10 | EXEL | Beckerle Mary C | Dir | S - Sale | $53.66 | -9,812 | 16.1K | -38% | -$526.5K |
| T | 2026-06-03 18:52 | 2026-06-01 | EXEL | WYSZOMIERSKI JACK L | Dir | S - Sale | $50.55 | -3,925 | 284.4K | -1% | -$198.4K |
| T | 2026-06-03 18:51 | 2026-06-01 | EXEL | Eckhardt Sue Gail | Dir | S - Sale | $50.14 | -9,812 | 16.1K | -38% | -$492.0K |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +8,367 | 1.20M | +0.7% | $0 | |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | Heyman Tomas J. | Dir | A - Grant | $0.00 | +8,367 | 50.6K | +20% | $0 | |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | Eckhardt Sue Gail | Dir | A - Grant | $0.00 | +8,367 | 25.9K | +48% | $0 | |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | Smith Julie | Dir | A - Grant | $0.00 | +8,367 | 29.0K | +41% | $0 | |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | Freire Maria C | Dir | A - Grant | $0.00 | +8,367 | 109.2K | +8% | $0 | |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | Beckerle Mary C | Dir | A - Grant | $0.00 | +8,367 | 25.9K | +48% | $0 | |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | Oliver Bob | Dir | A - Grant | $0.00 | +8,367 | 29.5K | +40% | $0 | |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | WYSZOMIERSKI JACK L | Dir | A - Grant | $0.00 | +8,367 | 288.3K | +3% | $0 | |
| 2026-05-29 17:43 | 2026-05-27 | EXEL | POSTE GEORGE | Dir | A - Grant | $0.00 | +8,367 | 127.2K | +7% | $0 | |
| 2026-05-28 18:25 | 2026-05-26 | EXEL | Aftab Dana | EVP, Research, Development | S - Sale | $50.35 | -43.5K | 594.7K | -7% | -$2.19M | |
| 2026-05-22 17:01 | 2026-05-20 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale | $49.81 | -32.1K | 357.6K | -8% | -$1.60M | |
| 2026-05-19 18:58 | 2026-05-15 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $51.10 | -128.5K | 1.49M | -8% | -$6.57M | |
| 2026-05-19 18:58 | 2026-05-18 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -124.0K | 1.36M | -8% | $0 | |
| I | 2026-05-19 18:58 | 2026-05-18 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | +124.0K | 2.00M | +7% | $0 |
| 2026-05-19 18:58 | 2026-05-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $51.10 | -40.9K | 987.2K | -4% | -$2.09M | |
| 2026-05-19 18:58 | 2026-05-18 | EXEL | Senner Christopher J. | EVP, CFO | S - Sale | $50.00 | -34.9K | 952.3K | -4% | -$1.75M | |
| 2026-05-19 18:58 | 2026-05-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $51.10 | -33.3K | 389.7K | -8% | -$1.70M | |
| T | 2026-05-19 18:58 | 2026-05-15 | EXEL | Hefti Brenda | SVP, GC | F - Tax | $51.10 | -6,411 | 113.4K | -5% | -$327.6K |
| T | 2026-05-19 18:58 | 2026-05-18 | EXEL | Hefti Brenda | SVP, GC | S - Sale | $50.21 | -6,625 | 106.8K | -6% | -$332.6K |
| 2026-05-19 18:58 | 2026-05-15 | EXEL | Aftab Dana | EVP, Research, Development | F - Tax | $51.10 | -30.6K | 638.2K | -5% | -$1.56M | |
| D | 2026-05-08 19:03 | 2026-05-07 | EXEL | Beckerle Mary C | Dir | M - OptEx | $23.24 | +3,856 | 25.2K | +18% | +$89.6K |
| D | 2026-05-08 19:03 | 2026-05-07 | EXEL | Beckerle Mary C | Dir | S - Sale+OE | $48.45 | -7,712 | 17.5K | -31% | -$373.6K |
| D | 2026-05-08 19:03 | 2026-05-07 | EXEL | Freire Maria C | Dir | M - OptEx | $19.77 | +20.6K | 121.5K | +20% | +$407.9K |
| D | 2026-05-08 19:03 | 2026-05-07 | EXEL | Freire Maria C | Dir | S - Sale+OE | $46.00 | -20.6K | 100.8K | -17% | -$949.2K |
| 2026-05-08 19:03 | 2026-05-07 | EXEL | POSTE GEORGE | Dir | S - Sale | $45.71 | -60.0K | 118.8K | -34% | -$2.74M | |
| I | 2026-05-08 19:03 | 2026-05-06 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -109.7K | 1.88M | -6% | $0 |
| 2026-03-02 | 2026-02-26 | EXEL | Hefti Brenda | SVP, GC | A - Grant | $0.00 | +23.1K | 119.6K | +24% | $0 | |
| I | 2026-03-02 | 2026-02-24 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -100.3K | 1.99M | -5% | $0 |
| 2026-03-02 | 2026-02-26 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +160.4K | 1.61M | +11% | $0 | |
| 2026-03-02 | 2026-02-26 | EXEL | Aftab Dana | EVP, Research, Development | A - Grant | $0.00 | +52.0K | 668.1K | +8% | $0 | |
| 2026-03-02 | 2026-02-26 | EXEL | Haley Patrick J. | EVP, Commercial | A - Grant | $0.00 | +40.5K | 422.4K | +11% | $0 | |
| 2026-03-02 | 2026-02-26 | EXEL | Senner Christopher J. | EVP, CFO | A - Grant | $0.00 | +52.0K | 1.03M | +5% | $0 | |
| 2026-02-26 | 2026-02-24 | EXEL | Aftab Dana | EVP, Research, Development | S - Sale | $44.50 | -47.9K | 616.1K | -7% | -$2.13M | |
| 2026-02-23 | 2026-02-19 | EXEL | Aftab Dana | EVP, Research, Development | S - Sale | $44.35 | -29.9K | 664.0K | -4% | -$1.32M | |
| D | 2026-02-20 | 2026-02-18 | EXEL | WYSZOMIERSKI JACK L | Dir | M - OptEx | $19.77 | +20.6K | 379.5K | +6% | +$407.9K |
| D | 2026-02-20 | 2026-02-18 | EXEL | WYSZOMIERSKI JACK L | Dir | S - Sale+OE | $44.01 | -99.6K | 279.9K | -26% | -$4.38M |
| DM | 2026-02-19 | 2026-02-17+ | EXEL | Smith Julie | Dir | M - OptEx | $19.34 | +106.5K | 63.0K | New | +$2.06M |
| DM | 2026-02-19 | 2026-02-17+ | EXEL | Smith Julie | Dir | S - Sale+OE | $44.00 | -106.5K | 20.6K | -84% | -$4.69M |
| DM | 2026-02-18 | 2026-02-13 | EXEL | Oliver Bob | Dir | S - Sale+OE | $43.81 | -30.2K | 42.3K | -42% | -$1.33M |
| D | 2026-02-18 | 2026-02-13 | EXEL | Oliver Bob | Dir | M - OptEx | $19.28 | +9,088 | 51.4K | +21% | +$175.2K |
| 2026-02-18 | 2026-02-13 | EXEL | Eckhardt Sue Gail | Dir | S - Sale | $43.79 | -3,856 | 17.5K | -18% | -$168.9K | |
| M | 2026-02-18 | 2026-02-13+ | EXEL | Senner Christopher J. | EVP, CFO | S - Sale | $43.32 | -64.9K | 976.1K | -6% | -$2.81M |
| 2026-02-18 | 2026-02-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $43.92 | -35.9K | 1.01M | -3% | -$1.58M | |
| 2026-02-18 | 2026-02-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $43.92 | -31.5K | 449.7K | -7% | -$1.38M | |
| M | 2026-02-18 | 2026-02-17 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale | $43.52 | -67.8K | 381.9K | -15% | -$2.95M |
| DM | 2026-02-18 | 2026-02-17+ | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -375.8K | 1.45M | -21% | $0 |
| DMI | 2026-02-18 | 2026-02-17+ | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | +375.8K | 2.09M | +22% | $0 |
| DM | 2026-02-18 | 2026-02-13+ | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $43.92 | -490.0K | 1.95M | -20% | -$21.52M |
| D | 2026-02-18 | 2026-02-13 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | M - OptEx | $21.31 | +494.7K | 2.32M | +27% | +$10.54M |
| M | 2026-02-18 | 2026-02-15 | EXEL | Aftab Dana | EVP, Research, Development | F - Tax | $43.92 | -39.2K | 706.6K | -5% | -$1.72M |
| 2026-02-18 | 2026-02-18 | EXEL | Hefti Brenda | SVP, GC | S - Sale | $44.01 | -18.7K | 96.5K | -16% | -$821.6K | |
| 2026-02-18 | 2026-02-15 | EXEL | Hefti Brenda | SVP, GC | F - Tax | $43.92 | -5,430 | 115.2K | -5% | -$238.5K | |
| 2026-01-16 | 2026-01-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $45.23 | -32.3K | 481.2K | -6% | -$1.46M | |
| 2026-01-16 | 2026-01-15 | EXEL | Haley Patrick J. | EVP, Commercial | A - Grant | $0.00 | +139.5K | 513.5K | +37% | $0 | |
| 2026-01-16 | 2026-01-15 | EXEL | Aftab Dana | EVP, Research, Development | A - Grant | $0.00 | +119.6K | 760.4K | +19% | $0 | |
| 2026-01-16 | 2026-01-15 | EXEL | Aftab Dana | EVP, Research, Development | F - Tax | $45.23 | -27.3K | 733.1K | -4% | -$1.23M | |
| 2026-01-16 | 2026-01-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $45.23 | -40.5K | 1.08M | -4% | -$1.83M | |
| 2026-01-16 | 2026-01-15 | EXEL | Senner Christopher J. | EVP, CFO | A - Grant | $0.00 | +149.5K | 1.12M | +15% | $0 | |
| 2026-01-16 | 2026-01-15 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +548.1K | 1.96M | +39% | $0 | |
| 2026-01-16 | 2026-01-15 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $45.23 | -139.5K | 1.83M | -7% | -$6.31M | |
| 2025-12-05 | 2025-12-03 | EXEL | Hefti Brenda | SVP, GC | A - Grant | $0.00 | +30.2K | 120.6K | +33% | $0 | |
| I | 2025-11-26 | 2025-11-25 | EXEL | Caligan Partners LP | Dir, See Remarks | P - Purchase | $43.12 | +27.5K | 1.55M | +2% | +$1.19M |
| M | 2025-11-24 | 2025-11-20+ | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale | $42.46 | -38.0K | 374.0K | -9% | -$1.62M |
| MI | 2025-11-24 | 2025-11-20 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale | $41.88 | -34.2K | 0 | -100% | -$1.43M |
| 2025-11-24 | 2025-11-21 | EXEL | Aftab Dana | EVP, Research, Development | G - Gift | $0.00 | -24.0K | 640.8K | -4% | $0 | |
| 2025-11-19 | 2025-11-17 | EXEL | Oliver Bob | Dir | G - Gift | $0.00 | -1,044 | 42.3K | -2% | $0 | |
| 2025-11-13 | 2025-11-11 | EXEL | Aftab Dana | EVP, Research, Development | S - Sale | $42.50 | -48.4K | 664.8K | -7% | -$2.06M | |
| MI | 2025-11-13 | 2025-11-11+ | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -138.5K | 1.69M | -8% | $0 |
| 2025-11-13 | 2025-11-12 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -101.5K | 1.42M | -7% | $0 | |
| DM | 2025-11-13 | 2025-11-11 | EXEL | Beckerle Mary C | Dir | S - Sale+OE | $41.93 | -24.6K | 40.2K | -38% | -$1.03M |
| D | 2025-11-13 | 2025-11-11 | EXEL | Beckerle Mary C | Dir | M - OptEx | $23.24 | +5,784 | 46.0K | +14% | +$134.4K |
| 2025-11-13 | 2025-11-12 | EXEL | PAPADOPOULOS STELIOS | Dir | S - Sale | $43.55 | -100.0K | 1.19M | -8% | -$4.36M | |
| 2025-10-10 | 2025-10-08 | EXEL | Aftab Dana | EVP, Research, Development | A - Grant | $0.00 | +50.7K | 713.2K | +8% | $0 | |
| M | 2025-06-04 | 2025-06-02 | EXEL | Eckhardt Sue Gail | Dir | S - Sale | $42.74 | -18.8K | 21.4K | -47% | -$805.1K |
| 2025-06-04 | 2025-06-03 | EXEL | WYSZOMIERSKI JACK L | Dir | S - Sale | $43.09 | -7,535 | 358.9K | -2% | -$324.7K | |
| 2025-05-30 | 2025-05-29 | EXEL | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +9,812 | 1.29M | +0.8% | $0 | |
| 2025-05-30 | 2025-05-29 | EXEL | WYSZOMIERSKI JACK L | Dir | A - Grant | $0.00 | +9,812 | 366.4K | +3% | $0 | |
| 2025-05-30 | 2025-05-29 | EXEL | Oliver Bob | Dir | A - Grant | $0.00 | +9,812 | 43.3K | +29% | $0 | |
| 2025-05-30 | 2025-05-29 | EXEL | POSTE GEORGE | Dir | A - Grant | $0.00 | +9,812 | 178.8K | +6% | $0 | |
| 2025-05-30 | 2025-05-29 | EXEL | Freire Maria C | Dir | A - Grant | $0.00 | +9,812 | 100.8K | +11% | $0 | |
| 2025-05-30 | 2025-05-29 | EXEL | Beckerle Mary C | Dir | A - Grant | $0.00 | +9,812 | 40.2K | +32% | $0 | |
| 2025-05-30 | 2025-05-29 | EXEL | Eckhardt Sue Gail | Dir | A - Grant | $0.00 | +9,812 | 40.2K | +32% | $0 | |
| 2025-05-30 | 2025-05-29 | EXEL | Smith Julie | Dir | A - Grant | $0.00 | +9,812 | 20.6K | +91% | $0 | |
| 2025-05-30 | 2025-05-29 | EXEL | Heyman Tomas J. | Dir | A - Grant | $0.00 | +9,812 | 42.3K | +30% | $0 | |
| 2025-05-22 | 2025-05-20 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale | $44.06 | -34.4K | 412.1K | -8% | -$1.52M | |
| 2025-05-22 | 2025-05-21 | EXEL | Heyman Tomas J. | Dir | S - Sale | $44.29 | -4,544 | 32.5K | -12% | -$201.3K | |
| DM | 2025-05-16 | 2025-05-14+ | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale+OE | $47.58 | -136.4K | 446.5K | -23% | -$6.49M |
| D | 2025-05-16 | 2025-05-15 | EXEL | Haley Patrick J. | EVP, Commercial | M - OptEx | $18.80 | +116.4K | 562.8K | +26% | +$2.19M |
| D | 2025-05-16 | 2025-05-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $44.65 | -34.7K | 456.5K | -7% | -$1.55M |
| D | 2025-05-16 | 2025-05-16 | EXEL | Senner Christopher J. | EVP, CFO | S - Sale+OE | $46.00 | -100.0K | 967.8K | -9% | -$4.60M |
| D | 2025-05-16 | 2025-05-16 | EXEL | Senner Christopher J. | EVP, CFO | M - OptEx | $18.80 | +100.0K | 1.07M | +10% | +$1.88M |
| D | 2025-05-16 | 2025-05-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $44.65 | -41.4K | 967.8K | -4% | -$1.85M |
| 2025-05-16 | 2025-05-15 | EXEL | Hessekiel Jeffrey | EVP, GC | F - Tax | $44.65 | -34.0K | 718.4K | -5% | -$1.52M | |
| 2025-05-16 | 2025-05-15 | EXEL | Hessekiel Jeffrey | EVP, GC | S - Sale | $46.18 | -25.0K | 693.4K | -3% | -$1.15M | |
| D | 2025-05-16 | 2025-05-16 | EXEL | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | S - Sale+OE | $45.47 | -72.8K | 465.4K | -14% | -$3.31M |
| D | 2025-05-16 | 2025-05-15 | EXEL | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | F - Tax | $44.65 | -8,303 | 498.2K | -2% | -$370.7K |
| D | 2025-05-16 | 2025-05-16 | EXEL | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | M - OptEx | $21.75 | +40.0K | 538.2K | +8% | +$870.0K |
Purchase Sale Sale after option exercise All abbreviations